Patient-reported perceptions, experiences and preferences around intravenous and oral antibiotics for the treatment of Staphylococcus aureus bacteremia: a descriptive qualitative study.
β
Just Accepted
#IDSky
π https://bit.ly/3Iil2JB
@amtatara.bsky.social
Physician scientist engaged in biomaterials, immunoengineering, and device-related infection. Assistant prof at UTSW.
Patient-reported perceptions, experiences and preferences around intravenous and oral antibiotics for the treatment of Staphylococcus aureus bacteremia: a descriptive qualitative study.
β
Just Accepted
#IDSky
π https://bit.ly/3Iil2JB
My teamβs new article is out!
For male basic trainees who had ICD-10 code for UTI or dysuria:
~50% had a sexual history documented
~70% had a gc/ct test ordered,
-Ultimate diagnosis of gc/ct >>> uti
-Few had any STI testing in 3 years following dysuria
#IDSky
academic.oup.com/milmed/advan...
Implanted devices risk biofilm infections. Biomaterial design affects infection risk, strength, and drug release. This review aids infectious disease clinicians in understanding biomaterials. π¦ π
#idsky
Many thanks for highlighting our work and giving us the opportunity to talk about the exciting intersection between host, microbe, and biomaterial!
14.07.2025 18:48 β π 2 π 0 π¬ 0 π 0We had a wonderful time looking at biomaterials through the lens of ID! Thanks for the RT
14.07.2025 11:46 β π 0 π 0 π¬ 0 π 0π Over 50% of LTCF residents in EU/EEA have HAIs. RTIs & UTIs make up nearly 50% of these infections.
#idsky
Many thanks to Jay Vyas for writing such an insightful commentary to our article in Clinical Infectious Diseases- pubmed.ncbi.nlm.nih.gov/40470539/.
12.06.2025 12:39 β π 0 π 0 π¬ 0 π 0Congrats to our fantastic ID fellow (Dr. Hannah Blanchard) and ID Faculty (Dr. Hayden Andrews, Dr. Netanya Utay) on their timely publication in @cidjournal.bsky.social on Measles immunity at our HIV clinic!! π
academic.oup.com/cid/advance-...
@bradcutrellmd.bsky.social @netanyautay.bsky.social
The disappointment after trying to buy dinosaur Elvis taught me a lot of life lessons
19.04.2025 18:25 β π 1 π 0 π¬ 0 π 0I remember playing this for hours at our library!! Canβt wait to watchβ¦
19.04.2025 18:24 β π 0 π 0 π¬ 1 π 0So neat! Do we know why?
17.04.2025 02:18 β π 1 π 0 π¬ 1 π 0@steventong.bsky.social presents the results of the PSSA domain of the SNAP π«° trial - the worlds largest trial of staph aureus bacteremia - at #ESCMID2025
fluclox resulted in higher mortality and more AKI compared to penicillin for PSSA
Weβve got something in review that addresses this question (as much as observational data can). Basically we think all ASPs the same compared to cefazolin
12.04.2025 20:48 β π 8 π 3 π¬ 2 π 0Dr Steven Tong presents data on Penicillin vs (Flu)Cloxacillin for penicillin sensitive S.aureus.
1. Penicillin is non-inferior.
2. Rate of AKI roughly half in Penicillin group.
3. More pts in Penicillin group changed Rx - why?
#ESCMIDGlobal
#ESCMIDGlobal starts soon π€
There's a new latebreaker session created to give 2-3 'big' trials their due: 'Trial Run', Sat 16:15
2 #SNAP trials + CloCeBa trial will be discussed in real detail Moderators @vancefowler.bsky.social +Julia Bielicki. @gurujosh.bsky.social @steventong.bsky.social #IDSky
Staphylococcus aureus bacteremia has a case fatality rate of 15% to 30% and causes 300 000 deaths per year worldwide. This Review discusses management of S aureus bacteremia. https://ja.ma/3RF8b50
07.04.2025 15:35 β π 24 π 9 π¬ 0 π 2We reviewed the latest in ID/Ortho collaborative models- institutional investment is important! www.sciencedirect.com/science/arti... @utswinfdis.bsky.social
06.04.2025 19:33 β π 6 π 2 π¬ 0 π 0SFB2025*
01.04.2025 01:44 β π 0 π 0 π¬ 0 π 0Come join us! Hiring a postdoc to work on immunotherapy to prevent and treat orthopaedic infection. I'll be at SFB2015 in Chicago if you want to chat about life in Dallas at our fabulous program. lnkd.in/evpKR5KE
lnkd.in/e7K2PMgh
π Study on 47 kids with musculoskeletal infections vs. 48 Lyme & 49 inflammatory arthritis. A 3-cytokine panel (IL-6, IL-17A, CSF-1) had AUC 0.90, outperforming 5 common biomarkers (P < .05).
#idsky
Excited to announce that we randomised our first patient in the @roadmaptrial.bsky.social today! First of thousands, answering important questions in prosthetic joint infection. See roadmaptrial.com for more deets. #IDSky #PJI #ROADMAP
24.03.2025 10:16 β π 35 π 10 π¬ 2 π 0Post-hoc analysis of π· π· study in MSSA/MRSA bacteremia:
Persistent fever = indicator for complicated infection
Fever on Day 4οΈβ£: aOR (3.7 (95% CI: 1.58-8.67)) mortality
Fever on Day 7οΈβ£: aOR: (8.78 (95% CI: 2.78-27.7)
π« assn between β¬οΈCRP/WBC and mortality
#IDSky
academic.oup.com/ofid/advance...
βIβll give you something to diarrhea aboutβ
24.01.2025 00:11 β π 1 π 0 π¬ 0 π 0In OFID, Seongman Bae and colleagues elucidate risk factors associated with 30-day infection-attributable mortality in a large cohort of patients with Staphylococcus aureus bacteremia (SAB).
09.01.2025 17:01 β π 1 π 1 π¬ 0 π 0Agreed! Just thought may be less inconvenient than micafungin infusions if that was an option you were considering
05.01.2025 15:46 β π 0 π 0 π¬ 1 π 0Havenβt used it and not ideal, but maybe rezafungin?
04.01.2025 22:29 β π 1 π 0 π¬ 1 π 0γMayo Clinic CME Orthopedic Infectious Diseases 2025γ
πComprehensive #OrthoID learning course is coming soon!
πGreat learning opportunity for #IDFellow #IMResident #OrthoResident!
ce.mayo.edu/orthopedic-s...
#IDMedEd #IDFellow #OrthoID #MayoClinicINFD #MSIS #EBJIS
#NIH funding is vital and the returns are superb, as noted by critical translational breakthroughs relevant to chronic fatigue, Parkinson's, prior diseases, cataracts, and hearing loss made with NIH funding in 2024
www.nih.gov/news-events/...